AmeriPharma’s premier pharmacy services are available in multiple states throughout the US.
Mon - Fri: 9:00AM - 10:00PM Sat - Sun: Closed

Related Posts

Welcome to Infusion Center

Get Financial Relief Now

Apply for Fulphila Copay Assistance

Free service matches you with top copay assistance programs

Specialists assist you throughout the application process

Get automated updates on your funding status

Over $55 million secured for our patients to date

How Much Can You Save?

Speak With a Copay Assistance Specialist

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances.

Medi-Cal logo
LegitScript approved

Get Started in Minutes

How Fulphila Copay Assistance Works

plus icon with transparent background

1 – Check Your Coverage/Benefits Verification

Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.

Rx icon

2 – Transfer Prescription to AmeriPharma

We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.

document icon with transparent background

3 – Prior Authorization

Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.

document and personnel icon with transparent background

4 – Copay Assistance & Financial Aid

We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma Specialty Care has secured $55 million in financial assistance for our patients.

3 hands and plus icon with transparent background

5 – Nursing Care Coordination

AmeriPharma puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.

box icon with transparent background

6 – Delivery Coordination

Medications are always delivered in strict compliance with the specific requirements for immune globulin shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.

Speak With a Specialist

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

What Is Fulphila?

Pegfilgrastim, which is also known by the brand name, Neulasta, is a hematopoietic agent that is used to treat neutropenia. Neulasta was the first medication produced based on the active element pegfilgrastim. Pegfilgrastim is not a hazardous drug, nor is it a form of chemotherapy.

Based on Neulasta, several different biosimilars have been produced, one of which is called Fulphila. Fulphila is similar to Neulasta in its mechanism of action, administration route, strength, and dosage.

Mechanism of Action

Pegfilgrastim is a blood cell colony-stimulating agent (CSA) and has been used successfully by cancer patients to stimulate the growth of white blood cells, more specifically neutrophils. It does this by stimulating the production of neutrophils directly from the bone marrow.

Schedule a Consultation

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

How Is Fulphila Used?

Fulphila has been approved by the Food and Drug Administration (FDA) for the treatment and prevention of (febrile) neutropenia caused by chemotherapy or radiation.

Available Formulations

Fulphila is only available as a subcutaneous (under the skin) injection. The injection is available as a single-use prefilled syringe for subcutaneous injection at a dose of 6 mg/0.6 mL. 

The injection sites can include upper areas of the buttocks, front of the thighs, lower abdomen area (2 inches away from the navel), or the upper outer arms. Do not inject into areas where the skin is tender, bruised, red, scaly, or hard, and avoid areas with scars or stretch marks. After injection, do not rub the injection site. Do not handle the prefilled syringe if you are allergic to latex, and do not save unused medication in the prefilled syringe for later use. You should not attempt to give yourself a subcutaneous injection until you have received the appropriate training from your healthcare provider.

Missed Dose

If you miss a dose, contact your physician immediately to reschedule.

Copay and Financial Assistance

AmeriPharma Specialty Care alleviates financial burdens for patients and their families

Advanced software icon
Advanced software locates funding sources to match you with top-dollar foundation programs
Copay assistance icon
One of our copay assistance specialists will assist with the application process
Funding status icon
Automatic updates will be sent to you and your physician on the status of the funding

Speak With a Specialist

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

Fulphila Side Effects

Serious side effects include:
  • Injection-site pain
  • Bone and muscle aches
  • Thrombocytopenia, leukocytosis
  • Lung problem called acute respiratory distress syndrome (ARDS)
  • Kidney injury
  • Capillary leak syndrome (CLS)
  • Inflammation of blood vessels
  • Rupture of the spleen
Less severe side effects include:
  • Sweating
  • Dark urine

Schedule a Consultation

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

Precautions

Unless approved by your physician, pegfilgrastim is generally not recommended for:

  • Patients who have an allergy to human granulocyte colony-stimulating factors (CFS) such as filgrastim or pegfilgrastim products. The needle cap on the prefilled syringe contains natural rubber (derived from latex). Do not handle the prefilled syringe if allergic to latex. Allergic reactions can cause a rash over the whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate, and sweating. If you have any of these symptoms, stop using Fulphila and call your doctor or get emergency help right away.
  • Patients with sickle cell disorder. Using Fulphila can lead to a condition called sickle cell crisis, which may be life-threatening and require discontinuation of Fulphila.
  • Patients receiving radiation therapy. Fulphila may increase the risk of developing a precancerous condition called myelodysplastic syndrome (MDS) or a type of blood cancer called acute myeloid leukemia (AML).

How Much Can You Save?

Speak With a Copay Assistance Specialist

© 2024 AmeriPharma Specialty Care. All Rights Reserved.  132 S. Anita Dr. 2nd Floor, Orange, CA 92868. Privacy Policy | Terms of use